Jeena Sikho Lifecare Ltd - 544476 - Corporate Action-Board approves Dividend
Jeena Sikho Lifecare Board recommended a final dividend of ₹4.50 per equity share for FY26. This dividend, representing 225% of the ₹2 face value, requires shareholder approval at the upcoming AGM.
May 30 2026 19:01:27
Jeena Sikho Lifecare Ltd - 544476 - Board Meeting Outcome for Declaration Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended 31St March , 2026.
Jeena Sikho Lifecare's board approved audited cons. financial results for FY26, with revenue of ₹801.36 crores and net profit of ₹221.70 crores. A final dividend of ₹4.50 per share was also recommended, subject to shareholder approval.
May 30 2026 18:16:54
Jeena Sikho Lifecare Ltd - 544476 - Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Studies And Case Reports.
Jeena Sikho Lifecare announced the publication of several Ayurvedic case studies and reports by its associated medical professionals in prominent international journals. These publications highlight the company's commitment to evidence-based Ayurvedic research and clinical practice.
May 25 2026 19:15:23
Jeena Sikho Lifecare Ltd - 544476 - Corporate Action-Board to consider Dividend
Jeena Sikho board to consider and recommend a final dividend for FY26 on May 30, 2026. This consideration is part of the board meeting agenda.
May 21 2026 15:30:56
Jeena Sikho Lifecare Ltd - 544476 - Board Meeting Intimation for Prior Intimation Of Meeting Of Board Of Directors Scheduled To Be Held On Saturday, 30Th Day Of May, 2026
Jeena Sikho Lifecare announced its Board of Directors will meet on May 30, 2026. The agenda includes considering and approving audited financial results for Q4 FY26 and the full financial year, along with recommending a final dividend for FY26.
May 21 2026 15:25:07
Jeena Sikho Lifecare Ltd - 544476 - Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Study And Case Reports.
Jeena Sikho Lifecare announced the publication of 7 case studies and 2 case reports by its medical professionals in the "Journal of Applied Science and Education". This demonstrates the company's commitment to Ayurvedic research and evidence-based clinical practice.
May 04 2026 19:12:48
Read More